Healthcare101

 The global point-of-care diagnostics market , valued at $49.7 billion in 2023, is projected to reach $77.8 billion by 2028, growing at a CAGR of 9.4%. Key drivers include the rising prevalence of infectious diseases like influenza, HIV, and tuberculosis, supportive government policies, and the shift towards healthcare decentralization. Challenges include pricing pressures due to reimbursement cuts and stringent regulatory approvals. Significant growth opportunities exist in emerging markets like China, India, Brazil, and Mexico. In 2022, glucose monitoring products held a significant market share, with lateral flow assays leading by platform. Major players include Abbott Laboratories , F. Hoffman-La Roche Ltd. , BD , Danaher Corporation , and Siemens Healthineers . Recent developments feature FDA approvals for new diagnostic panels by bioMérieux and BD, and a partnership between Thermo Fisher Scientific and Project HOPE to expand HIV testing in Sub-Saharan Africa. Download an Illu...

  The global point-of-care diagnostics market is expected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion in 2023, at a CAGR of 9.4% from 2023 to 2028. Key Growth Influencing Factors: Technological Advancements Expansion of Test Menu Personalized Medicine and Precision Diagnostics Integration with Telehealth and Remote Monitoring Point-of-Care Testing in Non-Traditional Settings Regulatory Landscape and Quality Assurance Point-of-Care Diagnostics in Global Health Initiatives Data Analytics and Artificial Intelligence (AI) Point-of-Care Diagnostics in Home Healthcare Collaboration and Partnerships To know about the assumptions considered for the study download the pdf brochure Technological Advancements: Continued advancements in technology, including miniaturization, automation, and connectivity, will drive innovation in point-of-care diagnostic devices. Emerging technologies such as microfluidics, lab-on-a-chip, and smartphone-based diagnostics will enable rap...

  The   global point-of-care diagnostics market   is expected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion in 2023, at a CAGR of 9.4% from 2023 to 2028. Market Size Introduction: The point-of-care diagnostics market size refers to the total valuation of products and services related to rapid testing and diagnostic solutions that can be performed at or near the point of patient care. These diagnostics enable quick and convenient testing outside of traditional laboratory settings, providing timely results for immediate clinical decision-making. Understanding the market size is crucial as it offers insights into the demand for point-of-care testing, technological advancements, regulatory landscape, and emerging trends driving market growth. This information serves as a foundation for strategic decision-making, investment planning, and assessing the potential for future expansion within the point-of-care diagnostics market. Key Factors: Current Valuati...